PharmaTell seminar: Assessing safety of dietary supplements: Adverse event analysis Event as iCalendar

21 March 2013

2:30 - 3:30pm

Venue: Room 505-364, Building 505, 85 Park Road, Grafton

Dr Hardy is the Medical Director of the Simms/Mann Integrative Oncology Program at UCLA, which involves educating cancer patients in integrative therapies. She is board certified in internal medicine and a specialist in botanical and integrative medicine, and has actively combined complementary and alternative therapies with traditional Western medicine for many years. Dr Hardy is recognized as an authority on integrative medicine and natural products by many organizations, including the Office of Dietary Supplements, the California Medical Board, the American Medical Association, and the American Pharmaceutical Association. Dr. Hardy serves on the scientific advisory board of the American Botanical Council, and was recently appointed to the External Advisory Council for the Natural Product Directorate for the Canadian government.

She is currently the co-director of the Integrative Medicine Health and Wellness Program at the Venice Family Clinic, the largest free clinic in the United States. Contributing to the national development of integrative medicine, she serves as the Co-chairperson of the Clinical Practice Committee of the Academic Consortium of Integrative Medicine (an organization of the leading medical schools practicing and teaching in this area). Her current research interests include reviewing the evidence for the safety and efficacy of natural therapies, especially botanicals.

Dr Hardy’s presentation will discuss methods and challenges in the assessment of dietary supplements and ‘natural health products’, and summarise case report data from the USA.